FDA Import Refusal 1FX-7099025-3/10002/3 — ABBOTT INDIA LIMITED
The FDA refused shipment 1FX-7099025-3/10002/3 from ABBOTT INDIA LIMITED (India) on June 1, 2026. The refused product falls under Drugs and Biologics — HOMEOPATHIC MULTIPLE INDICATIONS. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 1, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66XCA07 HOMEOPATHIC MULTIPLE INDICATIONS
- Charges
- 118,75